We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nobel Prize Awarded to Investigators of Telomeres and Telomerase

By LabMedica International staff writers
Posted on 12 Oct 2009
The 2009 Nobel Prize in Physiology or Medicine was awarded to three investigators who showed how chromosomes are completely copied during cell divisions and how they are protected against degradation.

Dr. Elizabeth Blackburn, professor of biology and physiology at the University of California, San Francisco (USA), and Dr. Jack Szostak, professor of genetics at Massachusetts General Hospital (Boston, USA) discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Dr. Carol Greider, professor of molecular biology and genetics at Johns Hopkins University (Baltimore, MD, USA) and Dr. Blackburn identified telomerase, the enzyme that makes telomere DNA.

Image: FISH light micrograph of human chromosomes (blue) showing telomeres (pink) that protect the ends of chromosomes (Photo courtesy of Arturo Londono / SPL).
Image: FISH light micrograph of human chromosomes (blue) showing telomeres (pink) that protect the ends of chromosomes (Photo courtesy of Arturo Londono / SPL).

These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.

Telomeres are extensions of the linear, double-stranded DNA molecules of which chromosomes are composed, and are found at each end of both of the chromosomal strands. In most eukaryotes telomeres consist of several thousand repeats of the specific nucleotide sequence TTAGGG and occur in organisms ranging from slime molds to humans.

The telomeres become shorter each time a cell divides. When the telomeres reach a specific short length, they signal the cell to stop dividing. Therefore, cellular aging, as marked by telomere shortening, is not based on the passage of time but rather on rounds of DNA replication.

Cancer cells escape telomere loss by switching on the gene that encodes for the enzyme telomerase. This enzyme is a reverse transcriptase that has an RNA template and a catalytic portion. At each round of DNA replication, telomerase adds onto the existing telomeres the nucleotides that would otherwise have been lost, thus maintaining a constant telomere length. Thus, telomerase acts as an "immortalizing" enzyme. In addition, it has several associated proteins whose roles are still under investigation.

Using the TRAP assay (telomeric repeat amplification protocol), it has been found that about 90% of all human tumors produce telomerase, whereas the only normal adult somatic cells that produce telomerase are stem cell populations found, for example, in skin, the hematopoietic system, germ cells, and gut epithelia.

The presence or absence of telomerase is the most specific property that distinguishes cancer cells from normal cells. This difference is currently under investigation as a diagnostic tool. If a chemical could be found to interfere with telomerase activity in cancer cells, an effective control of this disease might be found. Several candidate substances have been identified and are undergoing extensive studies in animals.

Related Links:
University of California, San Francisco
Massachusetts General Hospital
Johns Hopkins University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries